trending Market Intelligence /marketintelligence/en/news-insights/trending/dIz7qZjC1Kjb8JlvgIH9ag2 content esgSubNav
In This List

Meridian's blood-diagnostic system to be introduced in China

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Meridian's blood-diagnostic system to be introduced in China

MedCaptain Medical Technology Co. Ltd. secured a license to introduce Meridian Bioscience Inc.'s blood-diagnostic system in China.

The LeadCare II system, which will begin distributing in January 2017, is meant to diagnose lead exposure in the bloodstream.

MedCaptain will educate Chinese physicians and consumers about the risks and management of lead poisoning. Meridian estimates that between 9% and 25% of the Chinese population is exposed to lead as a result of the battery manufacturing/recycling, e-waste, mining and smelting industries.